National Institute of Allergy and Infectious Diseases (NIAID)
Atopic Dermatitis and Vaccinia Network
NIH / Other
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Change in anti-KLH IgG antibody response to two vaccinations of KLH in nonatopic participants
Safety of administering KLH by scarification route as measured by proportion of subjects with any treatment-emergent abnormalities in vital signs (body temperature, heart rate, respirations, and blood pressure) and liver function
Change in anti-KLH antibody responses in IgG subclasses 1 to 4, IgA, IgM, and IgE.
(and 6 more...)
18 Years to 40 Years (Adult)
DAIT ADVN KLH 07 Contract No. HHSN266200400029C
February 13, 2008
January 11, 2017
National Jewish Health Denver, Colorado, United States
† Study has passed its completion date and status has not been verified in more than two years.